← Back to headlines
Truist Analysts Adjust Price Targets Across Healthcare and Tech Stocks
Truist Securities has revised several stock ratings, raising targets for Jazz Pharmaceuticals and nCino based on clinical approvals and strong performance, while lowering its outlook for Intuit due to cautious guidance. The adjustments highlight shifting investor sentiment across healthcare, fintech, and software sectors.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
